Literature DB >> 17097921

Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.

Tetsuya Maeda, Ken Nagata, Hideaki Kondo, Takashi Kanbayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17097921     DOI： 10.1016/j.sleep.2006.05.017

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  6 in total

1.  Development of Parkinson's disease in patients with Narcolepsy.

Authors:  Chadwick W Christine; William J Marks; Jill L Ostrem
Journal:  J Neural Transm (Vienna)       Date:  2012-01-10       Impact factor: 3.575

2.  Narcolepsy: clinical differences and association with other sleep disorders in different age groups.

Authors:  Sona Nevsimalova; Juraj Pisko; Jitka Buskova; David Kemlink; Iva Prihodova; Karel Sonka; Jelena Skibova
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

Review 3.  RBD and Neurodegenerative Diseases.

Authors:  Haiyang Jiang; Jinsha Huang; Yan Shen; Shiyi Guo; Luxi Wang; Chao Han; Ling Liu; Kai Ma; Yun Xia; Jie Li; Xiaoyun Xu; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2016-03-31       Impact factor: 5.590

4.  Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder.

Authors:  Marcus M Unger; Jens C Möller; Tim Ohletz; Karin Stiasny-Kolster; Wolfgang H Oertel; Geert Mayer
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

5.  Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Authors:  Ko Tsutsui; Takashi Kanbayashi; Keiko Tanaka; Shuken Boku; Wakako Ito; Jun Tokunaga; Akane Mori; Yasuo Hishikawa; Tetsuo Shimizu; Seiji Nishino
Journal:  BMC Psychiatry       Date:  2012-05-08       Impact factor: 3.630

6.  A case of REM sleep behavior disorder, narcolepsy-cataplexy, parkinsonism, and rheumatoid arthritis.

Authors:  Filomena I I Cosentino; Angela Distefano; Giuseppe Plazzi; Carlos H Schenck; Raffaele Ferri
Journal:  Behav Neurol       Date:  2014-02-18       Impact factor: 3.342
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.